Audience
Healthcare AI solution for hospitals
About OM1
OM1 uses AI and big clinical data to dramatically improve research efficiency and clinical decision-making through high performance predictive models. OM1 Patient Finder uses proprietary, cutting-edge AI technology integrated with the OM1 Real-World Data Cloud. It incorporates different aspects of patients’ journeys from our range of data sources to identify patients at the greatest likelihood of having the target condition. We’ve built an intelligent data cloud to enable different healthcare stakeholders to cost-effectively access, analyze, and use outcomes data in a more robust, clinically meaningful, and precise way. Quickly, accurately, and more cost-effectively get to research-grade information on effectiveness, value, and safety. Quantify outcomes and demonstrate value in risk-sharing and outcomes-based payment models.
Other Popular Alternatives & Related Software
Oncora
Improving the quality of care and outcomes for cancer patients requires collaboration between physicians, scientists, cancer centers, and patients. Oncora's intuitive software platform allows all stakeholders to capture and apply real-world data for all healthcare-related decisions, for the benefit of the patient. Our products are built for healthcare professionals dedicated to improving cancer outcomes. Simplify workflow, reduce documentation burden, and optimize treatment with intelligent patient care software. Capture and visualize regulatory-grade real-world data with intuitive and dynamic software tools. Measure quality and streamline operations to improve care with advanced reporting tools. Rigorous clinical research with top cancer care professionals. Intuitive, web-based software to power your cancer center. Data and software to accelerate clinical discoveries.
Learn more
Altis Labs Nota
Altis Labs announces launch of Nota – a clinical information platform to accelerate therapeutic R&D Nota leverages. AI to predict patient outcomes from imaging data so sponsors can better prioritize their most promising therapies. Nota enables researchers to operationalize clinical trial imaging data, access predictive imaging biomarkers, and accelerate R&D at scale. Using Altis’ cloud-based software platform powered by deep learning, biopharma can incorporate comprehensive outcome predictions at the image, patient, and cohort level to improve clinical trial design and more confidently anticipate clinical endpoints. Such insights have the potential to significantly accelerate development timelines, lower drug development costs, and improve the likelihood of trial success across therapeutic areas.
Learn more
Savana
Savana is an AI-driven clinical intelligence platform that transforms unstructured electronic medical record text into deep real-world evidence through advanced natural language processing. Since its inception in 2014, Savana has enabled the structuring and analysis of billions of clinical documents across multiple languages and countries, unlocking previously hidden insights embedded within healthcare data. Its EHRead NLP models power anonymization and pseudonymization tools capable of handling both structured and free‑text data at scale, having processed over 35 million documents. Savana serves hospitals, researchers, and health systems by generating actionable, research-grade evidence to support precision medicine, epidemiological studies like COVID-19 predictive analyses, and broader clinical data strategies, all while remaining among Europe's top HEOR (Health Economics and Outcomes Research) contributors.
Learn more
ConcertAI
ConcertAI is a leading provider of AI-powered solutions in the healthcare industry, specializing in oncology. Their mission is to accelerate insights and improve outcomes for patients through leading real-world data, AI technologies, and scientific expertise. ConcertAI offers a suite of products and services designed to enhance clinical research and patient care. Their Real-World Data Products provide comprehensive, fit-for-purpose datasets that support a variety of research needs across the enterprise. The digital trial solution streamlines clinical trial processes, while the Clinical Trial Optimization (CTO) platform utilizes large-scale AI to refine trial design and execution in oncology and hematology. In collaboration with NeoGenomics, ConcertAI has developed CTO-H, a SaaS solution focused on hematological malignancies, offering advanced research analytics and operational optimization.
Learn more
Integrations
No integrations listed.
Company Information
OM1
Founded: 2015
United States
www.om1.com/solutions/aipredictivemedicine/
Videos and Screen Captures
Other Useful Business Software
Gemini 3 and 200+ AI Models on One Platform
Build generative AI apps with Vertex AI. Switch between models without switching platforms.
Product Details
Platforms Supported
Cloud
Support
Online
